1st Quarter - Report

TARPLIN, DOWNS & YOUNG, LLC for ASTRAZENECA

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

S. 1145/H.R. 1908 - Patent Reform Act of 2007 ***, no specific bill(s), Intellectual Properity

LobbyistCovered position, as disclosed
RAISSA H DOWNS Prin. Dep. Asst. Sec. for Leg. - HHS; Dept. Asst.
ISAAC A FORDJOUR —
LINDA E TARPLIN Means; Cmte. Staff, Sen. Cmte. on Finance

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 1908 (110th), S. 1145 (110th)

Medicare/Medicaid MMM

*see addendum page Medicare Physician Reimbursement Package, Medicare and Medicaid Drug Reimbursement H.R. 3162 - Children's Health and Medicare Protection Act of 2007 ***, no specific bill(s), Medicare and Medicaid Drug Reimbursement, Medicaid Rebate, Medicare Part D Non-Interference,

LobbyistCovered position, as disclosed
RAISSA H DOWNS Prin. Dep. Asst. Sec. for Leg. - HHS; Dept. Asst.
ISAAC A FORDJOUR —
LINDA E TARPLIN Means; Cmte. Staff, Sen. Cmte. on Finance

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); White House Office

Bills named: H.R. 3162 (110th)

Pharmacy PHA

*see addendum page ***, no specific bill(s), Drug Safety, DTC, Pediatric Drug Provisions, Compounding, Prescription Drug Importation

LobbyistCovered position, as disclosed
RAISSA H DOWNS Prin. Dep. Asst. Sec. for Leg. - HHS; Dept. Asst.
ISAAC A FORDJOUR —
LINDA E TARPLIN Means; Cmte. Staff, Sen. Cmte. on Finance

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE; Health & Human Services, Dept of (HHS)

Health Issues HCR

*see addendum page S. 558 - Mental Health Parity Act of 2007 S.2029 - Physician Payments Sunshine Act of 2007, Disclosure H.R. 5605 - Physician Payments Sunshine Act of 2008 Biosimilars H.R. 1956 - "Patient Protection and Innovative Biologic Medicine Act of 2007" H.R. 1038 - "Access to Life-Saving Medicine Act, Follow-On Biologics" S. 1695 - "Biologics Price Competition and Innovation Act of 2007" H.R. 5629 - "the "Pathway for Biosimilars Act"

LobbyistCovered position, as disclosed
RAISSA H DOWNS Prin. Dep. Asst. Sec. for Leg. - HHS; Dept. Asst.
ISAAC A FORDJOUR —
LINDA E TARPLIN Means; Cmte. Staff, Sen. Cmte. on Finance

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; White House Office

Bills named: S. 2029 (110th), S. 558 (110th), H.R. 1038 (110th), H.R. 5605 (110th), H.R. 1956 (110th), S. 1695 (110th), H.R. 5629 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.